Do you have a burning question about canaloplasty? Join Ike Ahmed and other experts to have your say.
Make sure to stop by Exhibit #C4.050 on Saturday and Sunday to take part in an interactive Q&A session to discuss the hottest topics in canaloplasty…
Have your say. Submit a question for our panel of canaloplasty experts.
Saturday, September 13
01:00 – 1:30 pm
Nova Eye Exhibit #C4.050
Sunday, September 14
Speaker Forum
01:00 – 1:30pm
Nova Eye Exhibit
Faculty:
Henny Beckers (Germany)
Paul I. Singh, MD (USA)
02:15 – 2:45pm
Nova Eye Exhibit
Faculty:
Ike Ahmed, MD (Canada)
Larissa Camejo, MD (USA)
Note: These sessions are not affiliated with the official program of the ESCRS 2025
Meet the experts at Exhibit #C4.050 to discuss surgical pearls and treatment tips for iTrack™ Advance.
Join us at the Nova Eye exhibit #C4.050 on Friday and Saturday for exclusive one-on-one time with canaloplasty experts. Discover surgical pearls, practical treatment tips, and insights into iTrack™ Advance.
Don’t miss this opportunity to learn from the best in the field.
Friday, September 14
2:00 – 3:00 pm
Nova Eye Exhibit #C4.050
Saturday, September 13
2:00 – 3:00 pm
Nova Eye Exhibit #C4.050
Note: These sessions are not affiliated with the official program of the ESCRS 2025.
Catch iTrack™ Advance during the “Modern MIGS Techniques not Using Implants” surgical skills lab.
Experience firsthand how canaloplasty with the iTrack™ Advance targets and treats all aspects of the conventional outflow pathway – without the need for hardware, and without tearing or removing tissue – to effectively reduce IOP in your glaucoma patients.
10:45am – 1:45pm
ESCRS Convention Center, Room 8
Learn more about the skills lab here: https://congress.escrs.org/sur…
Learn more about canaloplasty on the podium at ESCRS 2025.
Canaloplasty will be featured in several papers and posters at the ESCRS 2025. Please see the summary below and review the official ESCRS program for more details.
Sunday, September 14
“10-Year Efficacy and Safety of iTrack Ab-Interno Canaloplasty in Primary Open-Angle Glaucoma”
Norbert Koerber, PhD, MD (Germany)
2:00 – 3:30pm
(Session: Advances in Glaucoma Surgery)
Nobert Koerber, PhD, MD (Germany)
2:00 – 3:30pm
(Session: Advances in Glaucoma Surgery)
“Canaloplasty Effectiveness Correlated with Viscoelastic Volume Delivered”
Shamil Patel, MD, MBA (USA)
2:00 – 3:30pm
(Session: Advances in Glaucoma Surgery)
“Clinical Outcomes and Safety Profile of Standalone Canaloplasty vs. Canaloplasty Combined with Cataract Surgery Using iTrack Microcatheter”
Mary Qiu, MD
5:00 – 6:00pm
(Session: Advances in Glaucoma Surgery)
Monday, September 15
“Canaloplasty Performed with the iTrack Microcatheter to Reduce IOP in Uncontrolled Glaucoma Eyes”
Karl Mercieca, MD (Germany)
2:15 – 3:45pm
(Session: Contemporary Surgical Interventions in Glaucoma)
“24-Month Results of iTrack Global Data Registry to Support the Role of Canaloplasty for Treatment of Glaucoma”
Shamil Patel, MD (USA)
4:30 – 6:00pm
(Session: Contemporary Surgical Interventions in Glaucoma)
Posters
James Murphy (USA)
Efficacy and Safety Profile of Ab-Interno Canaloplasty Performed With and Without GATT in Uncontrolled Glaucoma Eyes – 24 Month Outcomes
Multicenter Canaloplasty Data Registry – Outcomes of Ab-Interno Canaloplasty Across Different Glaucoma Types and Severity
Want to know what all the fuss is about with iTrack™ Advance?
For over a decade, Nova Eye’s proprietary iTrack™ canaloplasty microcatheter has been used to treat more than 120,000 glaucoma patients around the world. Building on this trusted legacy, the latest generation iTrack™ Advance makes canaloplasty more efficient than ever before, thanks to its ergonomic all-in-one handpiece design. The unique design of the iTrack™ Advance allows you to perform canaloplasty over the entire 360º of the conventional outflow pathway via a single intubation. It also allows you to deliver 100+ microliters of hyaluronic acid-based viscoelastic via a pressurized mechanism designed to optimize dilation of the canal and the collector channels, and to stretch the trabecular meshwork.1 – 3
Ready to see the future of canaloplasty?
Visit us at exhibit #C4.050 to learn more.
Smit BA, Johnstone MA. Effects of viscoelastic injection into Schlemm’s canal in primate and human eyes: potential relevance to viscocanalostomy. Ophthalmology. 2002;109(4):786 – 792.3.Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25(3):316 – 322.4. Johnstone MA, Grant WM. Microsurgery of Schlemm’s canal and the human aqueous outflow system. Am J Ophthalmol 1973;76:906 – 17.